WASHINGTON, DC — LAWFUEL – The Law Newswire — April 24, 2007 — King & Spalding, a leading international law firm, announced today that David J. Bloch, a regulatory lawyer with significant experience counseling pharmaceutical, medical device and other healthcare clients on healthcare and FDA regulatory issues, has joined the firm as a partner in its FDA/Healthcare practice in Washington, D.C.
“We are pleased to welcome David to King & Spalding and look forward to the contributions he will make to our practice and our clients,” said John T. Bentivoglio, co-head of King & Spalding’s FDA/Healthcare practice. Added Mark S. Brown, co-head of the practice, “We believe David’s skill as a healthcare regulatory lawyer will strengthen our reputation as the ‘go to’ law firm for FDA regulatory matters.”
Bloch joins King & Spalding from Reed Smith LLP, where he was a partner. He represents clients on healthcare fraud, abuse and related compliance issues — an area of the pharmaceutical and medical device industry that is under intense scrutiny — and works with clients on a broad array of FDA issues. He has assisted companies in obtaining orphan drug designation for products under development, gained 510(k) clearance for new medical devices and successfully resolved potential recall actions for device manufacturers. He also has helped manufacturers develop marketing programs compliant with FDA requirements and mediated disputes with the FDA over marketing materials. On HIPAA and privacy matters, Bloch has assisted healthcare providers, drug and device manufacturers and others to develop HIPAA compliance programs and address the implications of HIPAA for their operations.
Bloch received a B.A. (cum laude) from Columbia University and a J.D. from the University of Pennsylvania.
“I am very pleased to be joining King & Spalding’s FDA/Healthcare practice. King & Spalding’s reputation in healthcare and regulatory issues, its remarkably talented lawyers and its focus on growth offer extraordinary opportunities for someone with my experience,” Bloch said.
King & Spalding’s Washington, D.C. office employs more than 150 lawyers and non-lawyer professionals, including government relations specialists, trade consultants and policy advisors. These lawyers and professionals practice in a broad range of areas including antitrust, class-action and mass tort litigation, commercial disputes, corporate finance, corporate governance, environmental, FDA/healthcare, public policy and government advocacy, government investigations, international trade, mergers and acquisitions and tax, among others.
Note to Editors: For a photo of David Bloch, please contact Matthew Hyams at 212-827-4057 or [email protected]
About King & Spalding
King & Spalding is an international law firm with more than 800 lawyers in Atlanta, Dubai, Houston, London, New York, Riyadh (affiliated office) and Washington, D.C. The firm represents half of the Fortune 100, and in a Corporate Counsel survey in August 2006 was ranked one of the top ten firms representing Fortune 250 companies overall. For additional information, visit www.kslaw.com.